TNGX
Tango Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.81 / 10
Netural
Capital flows are robust (fund flow score 7.94/10) with consistent inflows across all sizes (extra-large to small). Analyst consensus is overwhelmingly bullish (100% Strong Buy from Guggenheim), yet the broader sentiment score of 5.81 remains neutral, highlighting a gap between institutional conviction and market-wide perception.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-06
InstitutionGuggenheim
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for TNGX?
- TNGX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.81/10 (Netural).
